Actos Gets Stronger Bladder Cancer Warning, But Escapes Black Box
This article was originally published in The Pink Sheet Daily
Executive Summary
In an age of diabetes drug safety scares, will patients turn off of the thiazolidinedeione class altogether, or will the warning go unnoticed?